3rd-4th march, 2022. Final ENIUS Management Committee Meeting in Istanbul (Turkey) (CA16217). Core Group Meeting and ENIUS Workshop.

ENIUS organised its last MC Meeting in conjunction with the Workshop “Latest advances in Urinary Stents. Multidisciplinary approach”. During the first day, the Core Group Meeting and the MC Meeting took place, where all the activities carried out during these 4.5 years of ENIUS lifetime were reviewed. As well as the evaluation of all the objectives, milestones and tasks that are described in the MoU of the COST Action CA16217. To increase MC members' participation, this meeting was made hybrid, with members in Istanbul and others connected by videoconference. In summary, all the objectives proposed in the MOU were achieved.

The second day, also in hybrid format, was a Workshop where all the WGs were represented with different lectures, which were carried out by:

Dr. Nazli Atac. (Koc University, Istanbul-Turkey), Dr. Julia E. de la Cruz (JUMISC, Cáceres, Spain), Prof. Dilyana Gospodinova. (Technical University. Sofia, Bulgaria), Dr. Shaokai Zheng. (ARTOG, Center for Biomedical Engineering Research, Switzerland). 12.00-12.20h. Dr. Alexandre Barros. (I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics of University of Minho, Portugal). Maryam Mosayevi (University of Southampton, UK), Dr. Biljana Todorovic Markovic (Institute of Nuclear Sciences Vinca, University of Belgrade, Serbia), Dr. Noor Buchholz (U-Merge, Dubai&London), Prof. Declan Devine (Atholone Institute of Technology. Dublin,Ireland), Beatriz Domingues (I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics of University of Minho, Portugal), Margarida Pacheco. (I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics of University of Minho, Portugal), Nina Tomic. (Institute of Technical Sciences of SASA, Belgrade, Serbia) Antibacterial activity of the composite material resveratrol/selenium nanoparticles.

Organizing Committe: Prof. F. Can (Turkey) and Dr. F. Soria (Spain).